These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 15151617)

  • 21. Induction of apoptosis and cell cycle arrest by NS398 in oral squamous cell carcinoma cells via downregulation of E2 promoter-binding factor-1.
    Du Y; Zhang S; Wang Z; Zhou W; Luan M; Yang X; Chen N
    Oncol Rep; 2008 Sep; 20(3):605-11. PubMed ID: 18695912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclooxygenase-2 is a possible target of treatment approach in conjunction with photodynamic therapy for various disorders in skin and oral cavity.
    Akita Y; Kozaki K; Nakagawa A; Saito T; Ito S; Tamada Y; Fujiwara S; Nishikawa N; Uchida K; Yoshikawa K; Noguchi T; Miyaishi O; Shimozato K; Saga S; Matsumoto Y
    Br J Dermatol; 2004 Aug; 151(2):472-80. PubMed ID: 15327557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclooxygenase-2 expression in human esophageal carcinoma.
    Zimmermann KC; Sarbia M; Weber AA; Borchard F; Gabbert HE; Schrör K
    Cancer Res; 1999 Jan; 59(1):198-204. PubMed ID: 9892207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
    Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
    Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular pathology of cyclooxygenase-2 in neoplasia.
    Fosslien E
    Ann Clin Lab Sci; 2000 Jan; 30(1):3-21. PubMed ID: 10678579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A selective cyclooxygenase-2 inhibitor, NS-398, inhibits cell growth by cell cycle arrest in a human malignant fibrous histiocytoma cell line.
    Yamashita H; Osaki M; Honjo S; Yoshida H; Teshima R; Ito H
    Anticancer Res; 2003; 23(6C):4671-6. PubMed ID: 14981912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
    Bae SH; Jung ES; Park YM; Kim BS; Kim BK; Kim DG; Ryu WS
    Clin Cancer Res; 2001 May; 7(5):1410-8. PubMed ID: 11350912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
    Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW
    Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective cyclooxygenase-2 inhibition suppresses basic fibroblast growth factor expression in human esophageal adenocarcinoma.
    Baguma-Nibasheka M; Barclay C; Li AW; Geldenhuys L; Porter GA; Blay J; Casson AG; Murphy PR
    Mol Carcinog; 2007 Dec; 46(12):971-80. PubMed ID: 17477358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.
    Hu KQ; Yu CH; Mineyama Y; McCracken JD; Hillebrand DJ; Hasan M
    Int J Oncol; 2003 Apr; 22(4):757-63. PubMed ID: 12632065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthetic and naturally occurring COX-2 inhibitors suppress proliferation in a human oesophageal adenocarcinoma cell line (OE33) by inducing apoptosis and cell cycle arrest.
    Cheong E; Ivory K; Doleman J; Parker ML; Rhodes M; Johnson IT
    Carcinogenesis; 2004 Oct; 25(10):1945-52. PubMed ID: 15155531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Piroxicam is an ineffective inhibitor of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus.
    Carlton PS; Gopalakrishnan R; Gupta A; Liston BW; Habib S; Morse MA; Stoner GD
    Cancer Res; 2002 Aug; 62(15):4376-82. PubMed ID: 12154043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells.
    Wen B; Deutsch E; Eschwege P; De Crevoisier R; Nasr E; Eschwege F; Bourhis J
    J Urol; 2003 Nov; 170(5):2036-9. PubMed ID: 14532848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nimesulide and indomethacin induce apoptosis in head and neck cancer cells.
    Pelzmann M; Thurnher D; Gedlicka C; Martinek H; Knerer B
    J Oral Pathol Med; 2004 Nov; 33(10):607-13. PubMed ID: 15482327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of cyclooxygenase-2 with NS-398 and the prevention of radiation-induced transformation, micronuclei formation and clonogenic cell death in C3H 10T1/2 cells.
    Bisht KS; Bradbury CM; Zoberi I; Curry HA; Kaushal A; Roti Roti JL; Gius D
    Int J Radiat Biol; 2003 Nov; 79(11):879-88. PubMed ID: 14698956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of cyclooxygenase 2 in human malignant melanoma.
    Denkert C; Köbel M; Berger S; Siegert A; Leclere A; Trefzer U; Hauptmann S
    Cancer Res; 2001 Jan; 61(1):303-8. PubMed ID: 11196178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
    Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
    Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
    Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A study on cyclooxygenase-2 protein expression in esophageal carcinoma and premalignant lesions].
    Wang L; Zhang W; Wang W
    Zhonghua Zhong Liu Za Zhi; 2001 Jan; 23(1):14-6. PubMed ID: 11783060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclooxygenase-2 inhibitors demonstrate anti-proliferative effects in oesophageal cancer cells by prostaglandin E(2)-independent mechanisms.
    Deasy BM; O'Sullivan-Coyne G; O'Donovan TR; McKenna SL; O'Sullivan GC
    Cancer Lett; 2007 Oct; 256(2):246-58. PubMed ID: 17707579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.